This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) aims to develop an AI-powered data platform to address the challenge of "dark data" in materials science. The project by FUM Technologies, Inc., a small disadvantaged business located in Cambridge, MA, seeks to create a conversational digital expert system that can extract and synthesize valuable...
This $1,000,000 Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program aims to accelerate R&D in the pharmaceutical industry through the development of streamlined machine learning algorithms for small data applications in advanced manufacturing. The project, awarded to Sunthetics Inc., seeks to save time and resources by up to 95% in lead optimization and route scouting during pre-clinical drug development by...
The U.S. National Science Foundation awarded a $275,000 SBIR Phase I Project Grant to Om Therapeutics Inc. in La Jolla, CA under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to enable the discovery of new medicines at an unprecedented rate by empowering researchers to conduct drug discovery programs through the generation of massive, empirical, and scalable data on small molecule and protein interactions using machine learning. The key innovation is...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) grant of $274,932 awarded to Femtofluidics Incorporated aims to develop hardware that can rapidly and inexpensively synthesize DNA-encoded libraries (DELs) to accelerate drug discovery. The project proposes a novel approach to combinatorial chemistry using an electronic substrate that can manipulate nanoliter-to-picoliter volume droplets without any...
This $303,864 SBIR Phase I project grant awarded by the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) aims to develop a platform for the discovery of disruptive drug candidates. The project seeks to determine the biological laws driving diseases at the molecular network level and translate this understanding into an efficient, scalable algorithm for identifying new drug targets. The overarching goal is to enable the rapid design and...
This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program supports the development of a label-free, high-resolution, high-throughput protein screening platform called Vibrational Spectroscopy with Metasurface Optics (VISMO). The technology aims to enable simultaneous, minute-scale measurement of millions of protein samples, which would dramatically improve the lengthy and costly cycles...
This $274,904 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of an integrated computer vision capability to construct detailed 3D models from 2D photographs. The project aims to integrate geometric and semantic methods to accurately extract critical infrastructure asset features, such as utility pole height, inclination, wire gauges, deterioration, and...
This SBIR Phase I award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (TIP) program, with a total funding amount of $274,985, is focused on developing an artificial intelligence (AI) system to accelerate semiconductor production using physics-embedded lithographic foundation models. The project aims to alleviate design and manufacturing complexities associated with the shift to extreme ultraviolet (EUV) lithography in semiconductor manufacturing, which has...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant for $275,000 supports the development of a polymeric micelle platform to improve the solubility and stability of hydrophobic drugs. The key objectives are to: 1) optimize the formulation of spherical micelles for enhanced drug solubilization, 2) conduct initial toxicity studies to establish the safety of the platform, and 3) demonstrate the efficacy of the platform for solubilizing drug...
The National Science Foundation (NSF) awarded Insilicom LLC a $275,000 SBIR Phase I Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The grant supports the development of AI-powered, commercially viable applications enabled by Insilicom's large-scale biomedical knowledge graph. Key objectives include increasing the coverage of the knowledge graph, building a novel literature alert system called iPulse, and enhancing Insilicom's versatile query interface...